Skip to content
Lower risk Medical device recall · FDA · Published January 4, 2018

The Binding Site Group recalls Rheumatoid Factor Kit: Low/High Controls Return Invalid

The Binding Site Group recalls Rheumatoid Factor (RF) Kit for SPAPLUS analyser due to low and high controls returning results above assigned values. This may affect rheumatoid arthritis testing accuracy.

🇺🇸 FDA recall #Z-0553-2018Medical deviceThe Binding Site Group ›
Take action

Contact the company

Recalling firmThe Binding Site Group, Ltd.8 Calthorpe Road · Birmingham, United Kingdom
✎ GovInfoNow plain-language explainer

What happened, in plain English

The Binding Site Group recalls their Rheumatoid Factor (RF) Kit for SPAPLUS analyser because the low and high control samples give results higher than expected. This could lead to inaccurate rheumatoid arthritis test results if used without correction. Read more at govinfonow.com/recall/72170-the-binding-site-group-recalls-rheumatoid-factor-kit-low-high.

Source Summary by GovInfoNow · govinfonow.com/recall/72170-the-binding-site-group-recalls-rheumatoid-factor-kit-low-high · Updated August 31, 2026 · FDA enforcement record: FDA #Z-0553-2018

Cite this page

“The Binding Site Group recalls Rheumatoid Factor Kit: Low/High Controls Return Invalid.” GovInfoNow, updated August 31, 2026. https://govinfonow.com/recall/72170-the-binding-site-group-recalls-rheumatoid-factor-kit-low-high. Based on FDA recall #Z-0553-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0553-2018%22&limit=1).

Why it’s dangerous

The low and high control samples in the kit produce results that exceed the expected values. This could cause inaccurate measurements of rheumatoid factor in serum, potentially leading to incorrect diagnosis or treatment decisions.

Who’s affected

People using this kit for rheumatoid arthritis testing may be affected. Those with rheumatoid arthritis who rely on accurate lab results are most at risk.

How to tell if you have this one

Check for the product name 'Rheumatoid Factor (RF) Kit for SPAPLUS', product number LK151.S.A, and lot number 416595 (expired 31/03/2018).

  • Brand
    The Binding Site Group
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Details

    Verify the product number LK151.S.A and lot number 416595 on the kit label.

Where it went and when

Where it was distributed

Distributed in California.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “US Distribution was made to CA. There was no foreign/military/government distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California.

Recall timeline

FDA terminated this recall 2.4 years after the firm started it.

1. Firm started the recall: Jan 4, 201812. FDA classified it Class II: Feb 8, 201823. Published in FDA’s Enforcement Report: Feb 14, 201834. FDA terminated the recall: Jun 9, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0553-2018 (January 4, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0553-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 31, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA